✦ LIBER ✦

PP-7-17 Paclitaxel and carboplatin with G-CSF support in advanced breast cancer resistant to anthracyclines

✍ Scribed by G. Aravantinos; A. Athanassiadis; T. Giannakakis; D. Bafaloukos; P. Vlachostergiou; E. Briassoulis; P. Kosmidis; N. Pavlidis; D. Skarlos; G. Fountzilas

Book ID: 116168215
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 175 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(96)84234-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PP-7-6 Dose dense epirubicin (E) and pac

PP-7-6 Dose dense epirubicin (E) and paclitaxel (P) with G-CSF in metastatic breast cancer (MBC)

✍ J. Nortier; J. Wils; F. Erdkamp; R. Lalisang; J. Wals; H. Hillen; G. Blijham 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB

PP-7-18 Paclitaxel combinations with wee

PP-7-18 Paclitaxel combinations with weekly high dose 5-FU/Folinic acid and cisplatin in the treatment of metastatic breast cancer — there is a possible role of combining paclitaxel with anthracycline non cross resistant chemotherapeutic agents in the first and second line treatment I

✍ U. Klaassen; H. Wilke; D. Strumberg; C.Philippou Pari; C.H. Müller; W. Achterrat 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB